Works matching AU Bodegard, Johan

Results: 38

Dapagliflozin treatment of patients with chronic kidney disease without diabetes across different albuminuria levels (OPTIMISE-CKD).

Published in:

Clinical Kidney Journal, 2024, v. 17, n. 8, p. 1, doi. 10.1093/ckj/sfae100

By:

Svensson, Maria K;
Tangri, Navdeep;
Bodegård, Johan;
Eryd, Samuel Adamsson;
Thuresson, Marcus;
Sofue, Tadashi

Publication type:

Article

Population study of disease burden, management, and treatment of bipolar disorder in Sweden: a retrospective observational registry study.

Published in:

Bipolar Disorders, 2015, v. 17, n. 1, p. 76, doi. 10.1111/bdi.12234

By:

Carlborg, Andreas;
Ferntoft, Lena;
Thuresson, Marcus;
Bodegard, Johan

Publication type:

Article

Body weight and risk of atrial fibrillation in 7,169 patients with newly diagnosed type 2 diabetes; an observational study.

Published in:

Cardiovascular Diabetology, 2015, v. 14, n. 1, p. 109, doi. 10.1186/s12933-014-0170-3

By:

Grundvold, Irene;
Bodegard, Johan;
Nilsson, Peter M.;
Svennblad, Bodil;
Johansson, Gunnar;
Östgren, Carl Johan;
Sundström, Johan

Publication type:

Article

Incidence, prevalence and mortality of type 2 diabetes requiring glucose-lowering treatment, and associated risks of cardiovascular complications: a nationwide study in Sweden, 2006-2013.

Published in:

Diabetologia, 2016, v. 59, n. 8, p. 1692, doi. 10.1007/s00125-016-3971-y

By:

Norhammar, Anna;
Bodegård, Johan;
Nyström, Thomas;
Thuresson, Marcus;
Eriksson, Jan;
Nathanson, David

Publication type:

Article

Cost of healthcare utilization associated with incident cardiovascular and renal disease in individuals with type 2 diabetes: A multinational, observational study across 12 countries.

Published in:

Diabetes, Obesity & Metabolism, 2022, v. 24, n. 7, p. 1277, doi. 10.1111/dom.14698

By:

Norhammar, Anna;
Bodegard, Johan;
Eriksson, Jan W.;
Haller, Hermann;
Linssen, Gerard C. M.;
Banerjee, Amitava;
Karasik, Avraham;
Mamouris, Pavlos;
Tangri, Navdeep;
Taveira‐Gomes, Tiago;
Maggioni, Aldo P.;
Botana, Manuel;
Thuresson, Marcus;
Okami, Suguru;
Yajima, Toshitaka;
Kadowaki, Takashi;
Birkeland, Kåre I.

Publication type:

Article

Lower heart failure and chronic kidney disease risks associated with sodium‐glucose cotransporter‐2 inhibitor use in Japanese type 2 diabetes patients without established cardiovascular and renal diseases.

Published in:

Diabetes, Obesity & Metabolism, 2021, v. 23, p. 19, doi. 10.1111/dom.14119

By:

Komuro, Issei;
Kadowaki, Takashi;
Bodegård, Johan;
Thuresson, Marcus;
Okami, Suguru;
Yajima, Toshitaka

Publication type:

Article

Lower heart failure and chronic kidney disease risks associated with sodium‐glucose cotransporter‐2 inhibitor use in Japanese type 2 diabetes patients without established cardiovascular and renal diseases.

Published in:

Diabetes, Obesity & Metabolism, 2021, v. 23, p. 19, doi. 10.1111/dom.14119

By:

Komuro, Issei;
Kadowaki, Takashi;
Bodegård, Johan;
Thuresson, Marcus;
Okami, Suguru;
Yajima, Toshitaka

Publication type:

Article

Lower cardiorenal risk with sodium‐glucose cotransporter‐2 inhibitors versus dipeptidyl peptidase‐4 inhibitors in patients with type 2 diabetes without cardiovascular and renal diseases: A large multinational observational study.

Published in:

Diabetes, Obesity & Metabolism, 2021, v. 23, n. 1, p. 75, doi. 10.1111/dom.14189

By:

Birkeland, Kåre I.;
Bodegard, Johan;
Banerjee, Amitava;
Kim, Dae Jung;
Norhammar, Anna;
Eriksson, Jan W.;
Thuresson, Marcus;
Okami, Suguru;
Ha, Kyoung Hwa;
Kossack, Nils;
Mamza, Jil Billy;
Zhang, Ruiqi;
Yajima, Toshitaka;
Komuro, Issei;
Kadowaki, Takashi

Publication type:

Article

Heart failure and chronic kidney disease manifestation and mortality risk associations in type 2 diabetes: A large multinational cohort study.

Published in:

Diabetes, Obesity & Metabolism, 2020, v. 22, n. 9, p. 1607, doi. 10.1111/dom.14074

By:

Birkeland, Kåre I.;
Bodegard, Johan;
Eriksson, Jan W.;
Norhammar, Anna;
Haller, Hermann;
Linssen, Gerard C.M.;
Banerjee, Amitava;
Thuresson, Marcus;
Okami, Suguru;
Garal‐Pantaler, Elena;
Overbeek, Jetty;
Mamza, Jil Billy;
Zhang, Ruiqi;
Yajima, Toshitaka;
Komuro, Issei;
Kadowaki, Takashi

Publication type:

Article

Dapagliflozin vs non‐SGLT‐2i treatment is associated with lower healthcare costs in type 2 diabetes patients similar to participants in the DECLARE‐TIMI 58 trial: A nationwide observational study.

Published in:

Diabetes, Obesity & Metabolism, 2019, v. 21, n. 12, p. 2651, doi. 10.1111/dom.13852

By:

Norhammar, Anna;
Bodegard, Johan;
Nyström, Thomas;
Thuresson, Marcus;
Rikner, Klas;
Nathanson, David;
Eriksson, Jan W.

Publication type:

Article

Dapagliflozin vs non‐SGLT‐2i treatment is associated with lower healthcare costs in type 2 diabetes patients similar to participants in the DECLARE‐TIMI 58 trial: A nationwide observational study.

Published in:

Diabetes, Obesity & Metabolism, 2019, v. 21, n. 12, p. 2651, doi. 10.1111/dom.13852

By:

Norhammar, Anna;
Bodegard, Johan;
Nyström, Thomas;
Thuresson, Marcus;
Rikner, Klas;
Nathanson, David;
Eriksson, Jan W.

Publication type:

Article

Dapagliflozin and cardiovascular mortality and disease outcomes in a population with type 2 diabetes similar to that of the DECLARE‐TIMI 58 trial: A nationwide observational study.

Published in:

Diabetes, Obesity & Metabolism, 2019, v. 21, n. 5, p. 1136, doi. 10.1111/dom.13627

By:

Norhammar, Anna;
Bodegård, Johan;
Nyström, Thomas;
Thuresson, Marcus;
Nathanson, David;
Eriksson, Jan W.

Publication type:

Article

Exercise systolic blood pressure at moderate workload predicts cardiovascular disease and mortality through 35 years of follow-up in healthy, middle-aged men.

Published in:

Blood Pressure, 2017, v. 26, n. 4, p. 229, doi. 10.1080/08037051.2017.1291276

By:

Mariampillai, Julian E.;
Engeseth, Kristian;
Kjeldsen, Sverre E.;
Grundvold, Irene;
Liestøl, Knut;
Erikssen, Gunnar;
Erikssen, Jan;
Bodegard, Johan;
Skretteberg, Per Torger

Publication type:

Article

Early Versus Late Morning Measurement of Blood Pressure in Healthy Men. A Potential Source of Measurement Bias?

Published in:

Blood Pressure, 2002, v. 11, n. 6, p. 366, doi. 10.1080/080370502321095339

By:

Bodegard, Johan;
Erikssen, Gunnar;
Sandvik, Leiv;
Kjeldsen, Sverre E.;
Bjørnholt, Jørgen;
Erikssen, Jan E.

Publication type:

Article

Reasons for terminating an exercise test provide independent prognostic information: 2014 apparently healthy men followed for 26 years.

Published in:

European Heart Journal, 2005, v. 26, n. 14, p. 1394, doi. 10.1093/eurheartj/ehi278

By:

Bodegard, Johan;
Erikssen, Gunnar;
Bjørnholt, Jørgen V.;
Gjesdal, Knut;
Liestøl, Knut;
Erikssen, Jan

Publication type:

Article

Exercise testing of healthy men in a new perspective: from diagnosis to prognosis.

Published in:

European Heart Journal, 2004, v. 25, n. 11, p. 978, doi. 10.1016/j.ehj.2004.04.009

By:

Erikssen, Gunnar;
Bodegard, Johan;
Bjørnholt, Jørgen Vildershøj;
Liestøl, Knut;
Thelle, Dag S.;
Erikssen, Jan

Publication type:

Article

Heart failure outcomes by left ventricular ejection fraction in a contemporary region‐wide patient cohort.

Published in:

ESC Heart Failure, 2024, v. 11, n. 3, p. 1377, doi. 10.1002/ehf2.14685

By:

Sundström, Johan;
Ärnlöv, Johan;
Karayiannides, Stelios;
Bodegard, Johan;
Ersmark, Karolina;
Gustafsson, Stefan;
Cars, Thomas;
Svensson, Maria K.;
Norhammar, Anna

Publication type:

Article

Association Between Paradoxical HDL Cholesterol Decrease and Risk of Major Adverse Cardiovascular Events in Patients Initiated on Statin Treatment in a Primary Care Setting.

Published in:

Clinical Drug Investigation, 2016, v. 36, n. 3, p. 225, doi. 10.1007/s40261-015-0372-9

By:

Hasvold, Pål;
Thuresson, Marcus;
Sundström, Johan;
Hammar, Niklas;
Kjeldsen, Sverre;
Johansson, Gunnar;
Holme, Ingar;
Bodegård, Johan

Publication type:

Article

Interaction between inflammation and blood viscosity predicts cardiovascular mortality.

Published in:

Scandinavian Cardiovascular Journal, 2010, v. 44, n. 2, p. 107, doi. 10.3109/14017430903171248

By:

Skretteberg, Per Torger;
Bodegård, Johan;
Kjeldsen, Sverre E.;
Erikssen, Gunnar;
Thaulow, Erik;
Sandvik, Leif;
Erikssen, Jan E.

Publication type:

Article

Cross-sectional and longitudinal analyses of the association between lung function and exercise capacity in healthy Norwegian men.

Published in:

2018

By:

Farkhooy, Amir;
Bodegård, Johan;
Erikssen, Jan Erik;
Janson, Christer;
Hedenström, Hans;
Stavem, Knut;
Malinovschi, Andrei

Publication type:

journal article

Usefulness of Heart Failure Categories Based on Left Ventricular Ejection Fraction.

Published in:

Journal of the American Heart Association, 2024, v. 13, n. 8, p. 1, doi. 10.1161/JAHA.123.032257

By:

Christersson, Malin;
Gustafsson, Stefan;
Lampa, Erik;
Almstedt, Matilda;
Cars, Thomas;
Bodegård, Johan;
Arefalk, Gabriel;
Sundström, Johan

Publication type:

Article

Sodium–glucose cotransporter 2 inhibitors compared with other glucose‐lowering drugs in Japan: Subanalyses of the CVD‐REAL 2 Study.

Published in:

Journal of Diabetes Investigation, 2021, v. 12, n. 1, p. 67, doi. 10.1111/jdi.13321

By:

Kohsaka, Shun;
Takeda, Masayoshi;
Bodegård, Johan;
Thuresson, Marcus;
Kosiborod, Mikhail;
Yajima, Toshitaka;
Wittbrodt, Eric;
Fenici, Peter

Publication type:

Article

Temporal Reduction in Chronotropic Index Predicts Risk of Cardiovascular Death Among Healthy Middle-Aged Men: a 28-Year Follow-Up Study.

Published in:

Journal of the American Heart Association, 2016, v. 5, n. 12, p. 1, doi. 10.1161/JAHA.116.004555

By:

Engeseth, Kristian;
Hodnesdal, Christian;
Grundvold, Irene;
Liestøl, Knut;
Gjesdal, Knut;
Kjeldsen, Sverre E.;
Erikssen, Jan E.;
Bodegard, Johan;
Skretteberg, Per Torger

Publication type:

Article

Cardiovascular Events in Subgroups of Patients During Primary Treatment of Hypertension With Candesartan or Losartan.

Published in:

Journal of Clinical Hypertension, 2011, v. 13, n. 3, p. 189, doi. 10.1111/j.1751-7176.2010.00410.x

By:

Russell, David;
Stålhammar, Jan;
Bodegard, Johan;
Hasvold, Pål;
Thuresson, Marcus;
Kjeldsen, Sverre E.

Publication type:

Article

Suspected de novo heart failure in outpatient care: the REVOLUTION HF study.

Published in:

European Heart Journal, 2025, v. 46, n. 16, p. 1493, doi. 10.1093/eurheartj/ehaf034

By:

Anderson, Lisa;
Bayes-Genis, Antoni;
Bodegård, Johan;
Mullin, Katrina;
Gustafsson, Stefan;
Rosano, Giuseppe M C;
Sundström, Johan

Publication type:

Article

Cardiovascular and Renal Disease Burden in Type 1 Compared With Type 2 Diabetes: A Two-Country Nationwide Observational Study.

Published in:

2021

By:

Kristófi, Robin;
Bodegard, Johan;
Norhammar, Anna;
Thuresson, Marcus;
Nathanson, David;
Nyström, Thomas;
Birkeland, Kåre I.;
Eriksson, Jan W.

Publication type:

journal article

Comment on Suissa. Lower Risk of Death With SGLT2 Inhibitors in Observational Studies: Real or Bias? Diabetes Care 2018;41:6-10.

Published in:

2018

By:

Nyström, Thomas;
Bodegård, Johan;
Nathanson, David;
Thuresson, Marcus;
Norhammar, Anna;
Eriksson, Jan W.

Publication type:

Letter

232-LB: Cardiovascular Complications in T1D and T2D Patients Show More Similarities than Differences.

Published in:

Diabetes, 2019, v. 68, p. N.PAG, doi. 10.2337/db19-232-LB

By:

ERIKSSON, JAN W.;
BODEGARD, JOHAN;
NORHAMMAR, ANNA;
THURESSON, MARCUS;
NATHANSON, DAVID;
NYSTROM, THOMAS

Publication type:

Article

206-LB: Cardiorenal Disease Is the Most Common First CV Manifestation in Type 2 Diabetes and Associated with Increased Mortality: A Large Multinational Observational Study.

Published in:

Diabetes, 2019, v. 68, p. N.PAG, doi. 10.2337/db19-206-LB

By:

BIRKELAND, KARE I.;
BODEGARD, JOHAN;
THURESSON, MARCUS;
ERIKSSON, JAN W.;
NORHAMMAR, ANNA;
YAJIMA, TOSHITAKA;
KOMURO, ISSEI;
KADOWAKI, TAKASHI

Publication type:

Article

Patients with type 1 and type 2 diabetes hospitalized with COVID-19 in comparison with influenza: mortality and cardiorenal complications assessed by nationwide Swedish registry data.

Published in:

Cardiovascular Diabetology, 2022, v. 21, n. 1, p. 1, doi. 10.1186/s12933-022-01719-x

By:

Kristófi, Robin;
Bodegard, Johan;
Ritsinger, Viveca;
Thuresson, Marcus;
Nathanson, David;
Nyström, Thomas;
Norhammar, Anna;
Eriksson, Jan W.

Publication type:

Article

Epidemiology of the diabetes-cardio-renal spectrum: a cross-sectional report of 1.4 million adults.

Published in:

Cardiovascular Diabetology, 2022, v. 21, n. 1, p. 1, doi. 10.1186/s12933-022-01521-9

By:

Schechter, Meir;
Melzer Cohen, Cheli;
Yanuv, Ilan;
Rozenberg, Aliza;
Chodick, Gabriel;
Bodegård, Johan;
Leiter, Lawrence A.;
Verma, Subodh;
Lambers Heerspink, Hiddo J.;
Karasik, Avraham;
Mosenzon, Ofri

Publication type:

Article

Heart failure drug titration, discontinuation, mortality and heart failure hospitalization risk: a multinational observational study (US, UK and Sweden).

Published in:

European Journal of Heart Failure, 2021, v. 23, n. 9, p. 1499, doi. 10.1002/ejhf.2271

By:

Savarese, Gianluigi;
Bodegard, Johan;
Norhammar, Anna;
Sartipy, Peter;
Thuresson, Marcus;
Cowie, Martin R.;
Fonarow, Gregg C.;
Vaduganathan, Muthiah;
Coats, Andrew J.S.

Publication type:

Article

How representative of a general type 2 diabetes population are patients included in cardiovascular outcome trials with SGLT2 inhibitors? A large European observational study.

Published in:

Diabetes, Obesity & Metabolism, 2019, v. 21, n. 4, p. 968, doi. 10.1111/dom.13612

By:

Birkeland, Kåre I.;
Bodegard, Johan;
Norhammar, Anna;
Kuiper, Josephina G.;
Georgiado, Elena;
Beekman‐Hendriks, Wendy L.;
Thuresson, Marcus;
Pignot, Marc;
Herings, Ron M. C.;
Kooy, Adriaan

Publication type:

Article

Rates of myocardial infarction and stroke in patients initiating treatment with SGLT2‐inhibitors versus other glucose‐lowering agents in real‐world clinical practice: Results from the CVD‐REAL study.

Published in:

Diabetes, Obesity & Metabolism, 2018, v. 20, n. 8, p. 1983, doi. 10.1111/dom.13299

By:

Kosiborod, Mikhail;
Birkeland, Kåre I.;
Cavender, Matthew A.;
Fu, Alex Z.;
Wilding, John P.;
Khunti, Kamlesh;
Holl, Reinhard W.;
Norhammar, Anna;
Jørgensen, Marit E.;
Wittbrodt, Eric T.;
Thuresson, Marcus;
Bodegård, Johan;
Hammar, Niklas;
Fenici, Peter;
the CVD‐REAL Investigators and Study Group

Publication type:

Article

Dapagliflozin is associated with lower risk of cardiovascular events and all‐cause mortality in people with type 2 diabetes (CVD‐REAL Nordic) when compared with dipeptidyl peptidase‐4 inhibitor therapy: A multinational observational study

Published in:

Diabetes, Obesity & Metabolism, 2018, v. 20, n. 2, p. 344, doi. 10.1111/dom.13077

By:

Persson, Frederik;
Nyström, Thomas;
Jørgensen, Marit E.;
Carstensen, Bendix;
Gulseth, Hanne L.;
Thuresson, Marcus;
Fenici, Peter;
Nathanson, David;
Eriksson, Jan W.;
Norhammar, Anna;
Bodegard, Johan;
Birkeland, Kåre I.

Publication type:

Article

Novel oral glucose-lowering drugs are associated with lower risk of all-cause mortality, cardiovascular events and severe hypoglycaemia compared with insulin in patients with type 2 diabetes.

Published in:

Diabetes, Obesity & Metabolism, 2017, v. 19, n. 6, p. 831, doi. 10.1111/dom.12889

By:

Nyström, Thomas;
Bodegard, Johan;
Nathanson, David;
Thuresson, Marcus;
Norhammar, Anna;
Eriksson, Jan W.

Publication type:

Article

Physical fitness is a modifiable predictor of early cardiovascular death: A 35-year follow-up study of 2014 healthy middle-aged men.

Published in:

European Journal of Preventive Cardiology, 2018, v. 25, n. 15, p. 1655, doi. 10.1177/2047487318793459

By:

Engeseth, Kristian;
Prestgaard, Erik E;
Mariampillai, Julian E;
Grundvold, Irene;
Liestol, Knut;
Kjeldsen, Sverre E;
Bodegard, Johan;
Erikssen, Jan E.;
Gjesdal, Knut;
Skretteberg, Per Torger

Publication type:

Article

Long-term predictors of stroke in healthy middle-aged men.

Published in:

International Journal of Stroke, 2018, v. 13, n. 3, p. 292, doi. 10.1177/1747493017730760

By:

Prestgaard, Erik;
Hodnesdal, Christian;
Engeseth, Kristian;
Erikssen, Jan;
Bodegård, Johan;
Liestøl, Knut;
Gjesdal, Knut;
Kjeldsen, Sverre E.;
Grundvold, Irene;
Berge, Eivind

Publication type:

Article